Validation of a weight-based nomogram for the use of intravenous heparin in transient ischemic attack or stroke

被引:21
|
作者
Toth, C [1 ]
Voll, C [1 ]
机构
[1] Univ Saskatchewan, Royal Univ Hosp, Dept Med, Div Neurol, Saskatoon, SK S7N 0W8, Canada
关键词
heparin; ischemic attack; transient; nomogram; stroke;
D O I
10.1161/hs0302.104168
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Intravenous heparin therapy is often used in patients presenting with transient ischemic attack (TIA) or stroke as either bridging therapy for anticoagulation with warfarin or primary therapy in suspected intracranial arterial dissection, crescendo TIAs, or suspected hypercoagulable states. We attempted to validate the use or a weight-based nomogram for heparin-adjusted therapy during hospital admission of patients with TIA or stroke. Methods-A prospective, single-blinded, randomized, clinical trial was undertaken to compare the use of a specially designed, weight-based heparin nomogram against the traditional method of physician-ordered heparin therapy for patients admitted with TIA or stroke. The trial was not designed to examine the efficacy of heparin therapy but to examine the use of the nomogram for labor requirements, costs of monitoring, safety, length or heparin therapy, and user-friendliness. Results-Pretreatment clinical factors were comparable between those randomized to use of the nomogram (n = 101) and to usual care (n = 105). Nomogram patients had a significantly lower first activated partial thromboplastin time than nonnomogram patients (60.6 +/- 16.8 versus 69.8 +/- 28.7 seconds). Patients treated by nomogram achieved a therapeutic range of anticoagulation sooner than nonnomogram patients (13.4 +/- 17.0 versus 17.9 +/- 14.1 hours). The fraction of time during which anticoagulation was therapeutic was significantly greater in patients on nomogram therapy (74 +/- 25% versus 67 +/- 26%). Nomogram patients also had significantly fewer supratherapeutic coagulation results, significantly fewer dose adjustment mistakes, significantly fewer calls to house staff regarding anticoagulation, and significantly fewer total complications than nonnomogram patients. The times required for discontinuation of heparin and discharge from hospital were not significantly different. A survey of house staff and nursing staff showed a preference for nomogram use. Conclusions-The heparin nomogram is a user-friendly method of maintaining heparin infusions and is associated with improved anticoagulation measures, fewer total complications related to heparin therapy, fewer mistakes in heparin dosage adjustment, and decreased labor on the part of house staff and nursing staff.
引用
收藏
页码:670 / 674
页数:5
相关论文
共 50 条
  • [31] Transient ischemic attack and stroke associated with sildenafil (Viagra) use
    Morgan, JC
    Alhatou, M
    Oberlies, J
    Johnston, KC
    NEUROLOGY, 2001, 57 (09) : 1730 - 1731
  • [32] MANAGING TRANSIENT ISCHEMIC ATTACK AND ISCHEMIC STROKE
    MCIRVINE, AJ
    HIGMAN, DJ
    FRANKS, PJ
    BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6867): : 1498 - 1498
  • [33] MANAGING TRANSIENT ISCHEMIC ATTACK AND ISCHEMIC STROKE
    MARTIN, PJ
    GAUNT, ME
    BELL, PRF
    BRITISH MEDICAL JOURNAL, 1992, 305 (6867): : 1499 - 1499
  • [34] Comparison of a nurse-directed weight-based heparin nomogram with standard empirical doctor-based heparin dosage
    Fraipont, V
    Lambermont, B
    Moonen, M
    D'Orio, V
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2003, 22 (07): : 591 - 594
  • [35] Clinical Application of Intravenous Thrombolysis in Transient Ischemic Attack and Ischemic Stroke Guided by Multimodal MRI
    Song, Aixia
    Chen, Jing
    Sun, Yan
    Wang, Xiaoqin
    Zhang, Jichao
    Zou, Yuan
    Xue, Qian
    JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS, 2021, 11 (02) : 584 - 589
  • [36] Prevention of stroke in patients with ischemic stroke or transient ischemic attack
    Borja, Javier
    Izquierdo, Inaki
    Garcia-Rafanell, Julian
    STROKE, 2006, 37 (11) : 2653 - 2653
  • [37] Transient ischemic attack and secondary stroke
    Colin T. McDonald
    Walter J. Koroshetz
    Current Treatment Options in Neurology, 2000, 2 (4) : 329 - 341
  • [38] Management of stroke and transient ischemic attack
    Tuhrim, S
    MOUNT SINAI JOURNAL OF MEDICINE, 2002, 69 (03): : 121 - 130
  • [39] PROGNOSIS OF TRANSIENT ISCHEMIC ATTACK AND STROKE
    VANGIJN, J
    ALGRA, A
    KOUDSTAAL, PJ
    KAPPELLE, LJ
    VANSWIETEN, JC
    POP, GAM
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 741 - 741
  • [40] Clarification of weight-based heparin protocol
    Spruill, WJ
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (18) : 1788 - 1788